Source: International Business Times
Tech company GenBio is trying to combine different forms of biological information rather than relying on a single data type. Getty Images Scientists are developing artificial intelligence models that could simulate how human cells respond to drugs and genetic changes, potentially allowing researchers to test some ideas computationally before moving them into expensive laboratory experiments. GenBio AI is among the companies pursuing the technology.
Aller á la Source
Nouvelles connexes
